Pediatric PET/MR Image Registry

Launched by STANFORD UNIVERSITY · Mar 2, 2018

Keywords

ClinConnect Summary

The Pediatric PET/MR Image Registry is a clinical trial aimed at understanding how different imaging techniques can help in diagnosing tumors in children and young adults. Specifically, the study is comparing whole body magnetic resonance imaging (MR), whole body positron emission tomography (PET)/MR imaging, and, where available, PET/Computed Tomography (CT) imaging. The goal is to see which method is the most accurate for finding and diagnosing tumors such as soft tissue tumors, lymphoma, and osteosarcoma.

To participate in this study, patients must have a confirmed solid tumor or a new mass that is likely a solid tumor. The trial also considers some patients with leukemia if there are concerns about specific lesions in their organs. Participants under 18 will need their parents to provide consent, while those 18 and older can consent for themselves. It's important to note that not everyone can join; for instance, individuals with certain medical devices like pacemakers or specific health conditions may be excluded. If eligible, participants can expect to undergo various imaging tests, which will help researchers determine the best ways to diagnose tumors in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor.
• • We might also include some patients with leukemia if there is concern for a focal lesion in any of their organs.
• • Participant's parents (if participant is under 18) or the participant (if participant is 18 years or older) must willingly give written informed consent prior to any image transfer to the image registry.
• Exclusion Criteria:
• • Patient has contraindications for MRI or PET/MR. This includes patients with cardiac pacemakers or intracranial vascular clips as well as patients with a blood glucose level \> 200 mg/dl.
• • Lack of parental permission (if participant is younger than 18) or lack of informed consent (if participant is at least 18 years of age).
• • Patient has a CNS primary tumor.
• • Pregnant women and fetuses